Penumbra, Inc Revenue from Contract with Customer, Excluding Assessed Tax
Penumbra, Inc (PEN) reported Revenue from Contract with Customer, Excluding Assessed Tax of $390.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-30
- Penumbra, Inc revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $390.05M, a 14.90% increase year-over-year.
- Penumbra, Inc revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $374.76M, a 15.62% increase year-over-year.
- Penumbra, Inc revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $354.69M, a 17.82% increase year-over-year.
- Penumbra, Inc revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $339.45M, a 13.38% increase year-over-year.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month |
|---|---|---|---|
| 2026-06-30 | $390.05M 10-Q · filed 2026-07-30 | $764.80M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $374.76M 10-Q · filed 2026-05-06 | ||
| 2025-09-30 | $354.69M 10-Q · filed 2025-11-05 | $694.14M derived: sum of 2 quarters · filed 2026-07-30 | $1.02B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $339.45M 10-Q · filed 2026-07-30 | $663.60M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $324.14M 10-Q · filed 2026-05-06 | ||
| 2024-09-30 | $301.04M 10-Q · filed 2025-11-05 | $600.44M derived: sum of 2 quarters · filed 2025-11-05 | $879.10M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $299.40M 10-Q · filed 2025-07-29 | $578.06M 10-Q · filed 2025-07-29 | |
| 2024-03-31 | $278.65M 10-Q · filed 2025-04-23 | ||
| 2023-09-30 | $270.95M 10-Q · filed 2024-10-30 | $532.45M derived: sum of 2 quarters · filed 2024-10-30 | $773.84M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $261.50M 10-Q · filed 2024-07-30 | $502.90M 10-Q · filed 2024-07-30 | |
| 2023-03-31 | $241.40M 10-Q · filed 2024-05-07 | ||
| 2022-09-30 | $213.68M 10-Q · filed 2023-11-02 | $422.02M derived: sum of 2 quarters · filed 2023-11-02 | $625.92M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $208.34M 10-Q · filed 2023-08-01 | $412.24M 10-Q · filed 2023-08-01 | |
| 2022-03-31 | $203.90M 10-Q · filed 2023-05-02 | ||
| 2021-09-30 | $190.12M 10-Q · filed 2022-11-03 | $374.38M derived: sum of 2 quarters · filed 2022-11-03 | $543.58M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $184.26M 10-Q · filed 2022-08-05 | $353.46M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $169.20M 10-Q · filed 2022-05-03 | ||
| 2020-09-30 | $151.08M 10-Q · filed 2021-11-03 | $256.19M derived: sum of 2 quarters · filed 2021-11-03 | $393.51M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $105.11M 10-Q · filed 2021-08-09 | $242.44M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $137.33M 10-Q · filed 2021-05-04 | ||
| 2019-09-30 | $139.50M 10-Q · filed 2020-11-02 | $273.70M derived: sum of 2 quarters · filed 2020-11-02 | $402.14M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $134.20M 10-Q · filed 2020-08-03 | $262.64M 10-Q · filed 2020-08-03 | |
| 2019-03-31 | $128.44M 10-Q · filed 2020-05-07 | ||
| 2018-09-30 | $111.81M 10-Q · filed 2019-11-07 | $221.44M derived: sum of 2 quarters · filed 2019-11-07 | $324.14M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $109.64M 10-Q · filed 2019-08-06 | $212.34M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $102.70M 10-Q · filed 2019-05-07 | ||
| 2017-09-30 | $83.91M 10-Q · filed 2018-11-05 | $164.50M derived: sum of 2 quarters · filed 2018-11-05 | $237.71M 10-Q · filed 2018-11-05 |
| 2017-06-30 | $80.59M 10-Q · filed 2018-08-07 | $153.80M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $73.21M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |